Medicine has long known that killing healthy cells along with cancer tumor cells (chemo-therapy) is a clumsy, inefficient and painful way to go.
Immunotheraphy tries instead to 'wake up' the human immune system to go after rogue cells directly. The effort is finally paying off.
Stanford has developed a binary vaccine that's killing 97% of metastasized tumors in mice. The results are so conclusive that the University has already started trials on human lymphoma patients.
